SARAH SCHELL: Open Payments
NPI 1831685791 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$882 in 41 payments from 11 companies in 2025. Trend: 2023 $119 · 2024 $168 · 2025 $882
Food & beverage: $882
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $181 |
| Otsuka America Pharmaceutical, Inc. | 7 | $164 |
| ABBVIE INC. | 6 | $151 |
| Vanda Pharmaceuticals Inc. | 3 | $91 |
| Teva Pharmaceuticals USA, Inc. | 3 | $88 |
| Alkermes, Inc. | 4 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $52 |
| Neurocrine BioSciences, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Braeburn Inc. | 1 | $18 |
Products named: COBENFY, VRAYLAR, REXULTI, UZEDY, ARISTADA, FANAPT, INVEGA SUSTENNA, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
